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Abstract
PEPT2 is functionally active and localized to the apical
membrane of rat choroid plexus epithelial cells. However, little
is known about the transport mechanisms of endogenous
neuropeptides in choroid plexus, and the role of PEPT2 in this
process. In the present study, we examined the uptake kin-
etics of carnosine in rat choroid plexus primary cell cultures
and choroid plexus whole tissue from wild-type (PEPT2+/+)
and null (PEPT2–/–) mice. Our results indicate that carnosine
is preferentially taken up from the apical as opposed to
basolateral membrane of cell monolayers, and that baso-
lateral efflux in limited. Transepithelial flux of carnosine was
not distinguishable from that of paracellular diffusion. The
apical uptake of carnosine was characterized by a high affinity
(Km ¼ 34 lM), low capacity (Vmax ¼ 73 pmol/mg protein/min)
process, consistent with that of PEPT2. The non-saturable
component was small (Kd ¼ 0.063 lL/mg protein/min) and,
under linear conditions, was only 3% of the total uptake.
Studies in transgenic mice clearly demonstrated that PEPT2
was responsible for over 90% of carnosine’s uptake in choroid
plexus whole tissue. These findings elucidate the unique role
of PEPT2 in regulating neuropeptide homeostasis at the
blood–cerebrospinal fluid interface.
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Carnosine (b-alanyl-L-histidine) is present in muscle and the
central nervous system. Although the physiological function
of carnosine is not fully understood, many putative roles
have been assigned to this dipeptide. In this regard, it may act
as a neuroprotective agent against free radicals (Boldyrev
et al. 1997), inhibit protein glycosylation from reactive
aldehydes (Hipkiss et al. 1998), or act as a scavenger for
reactive oxygen species (Stvolinsky et al. 1999). Carnosine
reduces the toxicity of b-amyloid, the primary neurotoxin in
Alzheimer’s disease (Preston et al. 1998), and prevents
b-amyloid aggregation (Hipkiss 1998). It has also been
implicated in protection from metal-induced cell toxicity
(Horning et al. 2000). Finally, carnosine is present in high
concentrations (1–2 mM) in the olfactory bulb (Margolis
1974) and may serve as a neurotransmitter in this region
(Marchis et al. 2000).
PEPT2, a proton-coupled oligopeptide transporter, is
responsible for the high-affinity symport of di-/tripeptides
across biological membranes via an inwardly directed
electrochemical proton gradient. Although initially cloned
from human kidney (Liu et al. 1995), this peptide transporter
was subsequently cloned from rat brain and found to be
identical to rat kidney PEPT2 (Wang et al. 1998). PEPT2
transcripts are found throughout the brain and abundantly
expressed in epithelial cells of the choroid plexus (Berger
and Hediger 1999). Moreover, molecular and functional
studies conclusively demonstrate that PEPT2 protein is
expressed in choroid plexus tissue and, in particular, on the
apical membrane surface of choroidal epithelia (Novotny
et al. 2000; Teuscher et al. 2000, 2001; Shu et al. 2002). In
this capacity, PEPT2 is believed to act as an efflux pump in
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the removal of neuropeptides and peptide fragments from
cerebrospinal fluid (CSF).
Still, a clear understanding of neuropeptide transport at the
choroid plexus is lacking. This is due, in part, to the fact that
most choroid plexus studies were performed using a
synthetic, model dipeptide (i.e. glycylsarcosine), non-physio-
logic buffer conditions (e.g. Tris-Mes, acidic pH, low
sodium), and whole tissue uptakes that could neither differ-
entiate membrane sidedness nor directionality. In addition, the
presence of two peptide/histidine transporters in brain (i.e.
PHT1 and PHT2) (Yamashita et al. 1997; Sakata et al. 2001)
makes it difficult to accurately determine the significance of
PEPT2 relative to other (peptide) transporters. Notwithstand-
ing this uncertainty, it was reported that PEPT2 accounted for
about 60% of the total uptake of carnosine in whole tissue rat
choroid plexus (Teuscher et al. 2001). However, this conclu-
sion is quite tenuous, as suggested by other studies in PEPT2
null mice (Shen et al. 2003).
With this in mind, we used rat choroid plexus epithelial
cells in primary culture to investigate the peptide-mediated
transport mechanisms of an endogenous neuropeptide,
carnosine, at the blood–CSF interface. We also evaluated
the whole tissue choroid plexus uptake of carnosine in wild-
type and PEPT2-deficient mice. Taken as a whole, these
results indicate that apical PEPT2 is the predominant




[3H]Carnosine (9 Ci/mmol) was purchased from Moravek Bio-
chemicals (Brea, CA, USA) and [14C]mannitol (53 mCi/mmol) was
purchased from American Radiolabeled Chemicals (St Louis, MO,
USA). Amino acids (b-alanine and L-histidine), carnosine, glycyl-
glutamine (GlyGln), glycylsarcosine (GlySar), 4-acetamido-4¢-iso-
thiocyanatostilbene-2,2¢-disulfonic acid (SITS), taurocholic acid
(TCA), c-amino-n-butyric acid (GABA), p-aminohippuric acid
(PAH), N1-methylnicotinamide (NMN), tetraethylammonium
(TEA) and choline were purchased from Sigma (St Louis, MO,
USA). Other chemicals were obtained from standard sources and
were of the highest quality available.
Culture medium and uptake buffers
The cell culture medium consisted of Dulbecco’s modified Eagle’s
medium (DMEM)/F-12 (1 : 1) supplemented with 10% (v/v) fetal
bovine serum, 15 mM HEPES, 2 mM L-glutamine, 100 units/mL
penicillin G sodium, 1 lg/mL streptomycin sulfate, 25 lg/mL
gentamicin, 5 mg/mL insulin, 10 ng/mL epidermal growth factor,
2 lg/mL hydrocortisone, 5 lg/mL transferrin, and 5 ng/mL sodium
selenite (pH 7.3) (all reagents from Life Technologies, Rockville,
MD, USA).
Experiments were performed in normal-Na+ artificial cerebro-
spinal fluid (aCSF) and low-Na+ aCSF. The normal-Na+ aCSF
buffer (about 310 mOsm/kg) contained 127 mM NaCl, 20 mM
NaHCO3, 2.4 mM KCl, 0.5 mM KH2PO4, 1.1 mM CaCl2, 0.85 mM
MgCl2, 0.5 mM Na2SO4, and 5.0 mM glucose. In the low-Na
+ aCSF
buffer, NaCl and NaHCO3 were replaced with choline chloride and
choline bicarbonate, respectively, producing a 1.0 mM sodium
solution due to the presence of Na2SO4. Both buffers were adjusted
to pH 7.4 with HCl.
Primary culture of choroid plexus epithelial cells
Primary cultures of rat choroid plexus epithelial cells were prepared
from 1 to 2 day-old neonatal rats using an established method
(Strazielle and Ghersi-Egea 1999; Shu et al. 2002). Cells were
isolated from lateral ventricles and seeded on laminin-coated
Transwell-Clear filter inserts (12-mm diameter, 0.4-lm pore size;
Costar Plastics, Cambridge, MA, USA). The culture medium was
changed at 48–72 h after seeding and every other day thereafter.
Cells were grown in a sterile incubator at 37C, 95% relative
humidity and 5% CO2. Cultures were inspected visually for
epithelial growth (cobblestone appearance) on a weekly basis.
Confluence occurred at 5–7 days post-seeding. Transepithelial
electrical resistance measurements were performed prior to experi-
mentation (using a Millicell-ERS; Millipore Corp., Bedford, MA,
USA) as a measure of monolayer integrity. Values of 150 W•cm2
were reached at 10–14 days post-seeding and were considered
sufficient for experimentation.
Carnosine intracellular accumulation and transepithelial
transport in cell cultures
Cells were incubated apically (0.4 mL) and basolaterally (1.2 mL)
in uptake buffer (normal-Na+ aCSF or low-Na+ aCSF) at 37C for
10 min prior to experimentation. The buffer was removed and fresh
uptake buffer, containing 0.4 lCi [3H]carnosine and 0.1 lCi
[14C]mannitol, was added to the apical (0.4 mL) or basolateral
(1.2 mL) chamber; control buffer (no radioisotope) was added to the
opposite chamber. Potential inhibitors (1 mM) were added to the
same side as carnosine. The cells were then incubated at 37C for
the indicated time. To measure transepithelial transport, a 100 lL
sample was taken from the opposite chamber and placed in a
scintillation vial. To measure intracellular accumulation, the uptake
buffer was aspirated at the end of the incubation period. Three
successive rapid washings with ice-cold uptake buffer were then
performed. The filter and monolayer were detached and placed in a
scintillation vial with 0.5 mL of 0.2 M NaOH and 1% sodium
dodecyl sulfate (SDS). Scintillation cocktail [EcoLite(+); ICN,
Costa Mesa, CA, USA] was added to the solubilized cells and
radioactivity was determined in the sample using a dual-channel
liquid scintillation counter (Beckman LS 6000; Fullerton, CA,
USA). The protein content of the solubilized cell monolayers was
determined by the method of Bradford (1976), using a Bio-Rad
protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) with
immunoglobulin G as the standard.
Carnosine uptake data were corrected for filter binding and
extracellular content, as described previously (Teuscher et al. 2000).
The transepithelial transport of carnosine was corrected for
paracellular flux, as estimated by mannitol (Shu et al. 2002).
Efflux experiments in cell cultures
Cells were washed twice with normal-Na+ aCSF buffer and then
incubated apically (0.4 mL) and basolaterally (1.2 mL) in this buffer
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at 37C for 10 min prior to experimentation. The buffer was
removed and fresh uptake buffer containing 1 lM [3H]carnosine was
added to the apical chamber (0.4 mL); control buffer (no radioiso-
tope) was added to the basolateral chamber. The cells were then
incubated at 37C for 2 hours. The cells were removed and washed
six times with warm buffer. Fresh normal-Na+ aCSF buffer was then
added to the apical (0.4 mL) and basolateral (1.2 mL) chambers. At
the indicated times, a 100-lL aliquot was sampled from the apical
and basolateral chambers, and added to a scintillation vial. At the
final time point, the cell monolayers were washed and removed, and
placed in a scintillation vial with lysis buffer. Scintillation cocktail
[Ecolite(+); ICN, Costa Mesa, CA, USA] was added to the samples
and radioactivity determined using a dual-channel liquid scintilla-
tion counter (Beckman LS 6000). Efflux was expressed as the per
cent of total substrate in the cells after loading.
Carnosine stability in cell cultures
Choroid plexus epithelial cells were incubated apically with 1 lM
[3H]carnosine for 15, 30, 60 and 120 min. At the end of incubation,
media from the apical and basolateral compartments were aspirated
and saved for analysis. The cell monolayers were washed three
times with ice-cold buffer and solubilized in 0.5 mL of 0.2 M NaOH
and 1% SDS. The samples were then analyzed by high-performance
liquid chromatography (HPLC), and the concentration of radiolabe-
led carnosine and its potential degradation product, histidine, was
determined. The stability of carnosine was evaluated by its recovery
and the appearance of histidine following incubation. Results were
reported from three separate experiments.
An analytical method was developed based on work done by
O’Dowd et al. (1990). Carnosine and histidine were detected using
an HPLC system consisting of a pump (Waters, Model 616, Milford,
MA, USA), a controller (Waters, Model 600S), a reversed-phase
column (Hypersil ODS, C-18, 5 lm, 250 mm · 4.6 mm, Alltech,
Deerfield, IL, USA) and a radiochromatography detector (FLO-
ONE 500TR, Packard Instrument Co., Meriden, CT, USA). The
mobile phase was comprised of 0.1 M Na2HPO4 and 0.13%
heptafluorobutryic acid, and pumped isocratically at 1 mL/min at
room temperature (23C). Retention times for histidine and
carnosine were 6.9 and 18.5 min, respectively.
Endogenous carnosine
Skeletal muscle (600 mg), olfactory bulb (450 mg), choroid plexus
(70 mg), cerebrospinal fluid (200 lL) and plasma (3 mL) were
obtained from anesthetized adult female rats, and processed accord-
ingly (O’Dowd et al. 1990). In brief, tissue samples were homogen-
ized in 2 mL of water. An 8-mL aliquot of ethanol was added to the
homogenized tissue and body fluid samples, and the mixture was
vortexed and then incubated at 60C for 90 min. After incubation, the
precipitate was pelleted by centrifugation (2000 g, 15 min). The
supernatant was removed, evaporated to dryness, and then reconsti-
tuted in mobile phase. Carnosine was detected at 210 nm using a UV
spectrophotometer (Spectroflow 783; ABI Analytical, Chestnut
Ridge, NY, USA) coupled to HPLC (as described above).
Carnosine uptake in isolated choroid plexuses of PEPT2+/+
and PEPT2–/– mice
Whole tissue choroid plexus uptakes were performed in 30–50-day-
old PEPT2+/+ (wild-type) and PEPT2–/– (null) mice, as described
previously for GlySar (Shen et al. 2003). In brief, lateral and fourth
ventricle choroid plexuses were harvested from anesthetized mice,
transferred to pre-weighed eppendorf tubes and re-weighed to
0.1 mg accuracy using an electronic balance (Mettler AE100;
Toledo, OH, USA) to determine plexus weight. They were then
immediately transferred to normal-Na+ aCSF buffer (pH 7.4) which
was continuously bubbled with 5% CO2, 95% O2. After a 5-min
recovery period, the choroid plexuses were transferred to 0.95 mL
of fresh buffer for 0.5 min. Uptake was initiated by addition of
0.05 mL of normal-Na+ aCSF buffer containing about 0.2 lCi of
[3H]carnosine (plus 20 lM unlabeled carnosine) and 0.2 lCi
of [14C]mannitol (an extracellular marker), resulting in a final
carnosine concentration of 1.0 lM. Uptake was terminated after
2 min by transferring the plexuses to ice-cold buffer and filtering
under reduced pressure. The filters (118-lm mesh, Tetko, Kansas
City, MO, USA) were washed three times with the same buffer. The
filters and choroid plexuses were then soaked in 0.33 mL of 1 M
hyamine hydroxide (a tissue solubilizer) for 30 min before the
addition of scintillation cocktail (Cytoscint) and counting with a
dual-channel liquid scintillation counter (Beckman LS 3801).
Similar uptake studies were performed for carnosine in low-Na+
aCSF buffer (pH 7.4). The uptake of radiolabeled carnosine into
choroid plexus (Vd, in lL/mg of wet tissue weight) was calculated as
described previously (Teuscher et al. 2000).
All of the rat and mice experiments were carried out in
accordance with animal care guidelines and with the approval of
the University of Michigan Committee for the Care and Use of
Animals.
Data analysis
For concentration-dependent studies in cell cultures, the datawere best
fit to the equation: carnosine uptake ¼ Vmax ? C/(Km + C) + Kd ? C,
where Vmax is the maximal rate of saturable carnosine uptake,
Km is the Michaelis constant, C is the substrate (carnosine)
concentration, and Kd is the non-saturable rate constant. To evaluate
if more than one class of transporters was operational for carnosine, a
Woolf-Augustinsson-Hofstee transformation of the saturable portion
of uptake (V ¼ carnosine uptake – Kd ? C) was performed in which:
V ¼ Vmax – Km ? V/C.
Statistical comparisons were performed with ANOVA (SYSTAT,
version 8.0; SPSS Inc., Chicago, IL, USA) and pairwise compar-
isons were made with Dunnett’s test. A probability of p ¼ 0.05 was
considered statistically significant. Linear and non-linear regression
analyses were performed with SCIENTIST (version 2.01; MicroMath
Scientific Software, Salt Lake City, UT, USA) and a weighting
factor of unity. The quality of fit was determined by evaluating the
coefficient of determination (r2), the standard error of parameter
estimates, and by visual inspection of the residuals. Data are
reported as mean ± SE.
Results
Apical versus basolateral uptake and efflux of carnosine
in cell cultures
The time course of [3H]carnosine uptake in normal-Na+
aCSF is shown in Fig. 1. The uptake rate was 5–6 times
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greater from the apical than from the basolateral surface. The
apical uptake was linear through 120 min, at which time
there was approximately a 135 : 1 ratio of intracellular to
extracellular carnosine, indicating active accumulation from
CSF into the cell. Based on these results, a 60-min incubation
time was chosen for initial rate uptakes of carnosine in order
to maximize its sensitivity for kinetic and amino acid/
dipeptide inhibitor studies. Alternatively, a 15-min incuba-
tion time was chosen for carnosine studies with charged
compounds (i.e. organic anion or cation inhibitors) so that
potential intracellular and/or extracellular pH changes would
be minimized. Stability was not an issue in our experimental
system as ‡ 99.3% of carnosine was recovered intact from
the apical, basolateral and intracellular compartments, even
after 2 hours of incubation.
To probe the fate of carnosine once in the cell, efflux was
examined after a 2-h pre-loading period. As shown in Fig. 2,
at 25 min, about 20% of [3H]carnosine was effluxed to the
apical chamber while only 5% was effluxed to the basolateral
chamber. The apical efflux was similar to values determined
previously for GlySar in rat choroid plexus primary cell
cultures (Shu et al. 2002). Although the uptake of carnosine
occurred primarily at the apical membrane, its apical to basal
transport could not be discerned from that of mannitol alone
(data not shown). The lack of measurable transepithelial
transport agrees with very minor efflux of carnosine into the
basolateral compartment. Due to the dominance of carno-
sine’s apical uptake, along with PEPT2 being localized to the
apical surface of choroid plexus epithelial cells, the speci-
ficity and kinetic properties of carnosine were characterized
further at this membrane surface alone.
Apical uptake of carnosine ± inhibitors in cell cultures
The specificity of peptide-mediated transport was examined
using physiologic normal-Na+ aCSF versus low-Na+ aCSF
buffer and a wide variety of potential inhibitors. As shown
in Fig. 3(a) (physiologic buffer), neither b-alanine nor
L-histidine, the constituent amino acids of carnosine, were
able to inhibit uptake. However, unlabeled carnosine as well
as two dipeptides, GlyGln and GlySar, reduced [3H]
carnosine uptake to values that were 5–10% of control. A
similar inhibition profile was observed when radiolabeled
carnosine was studied under low sodium conditions
(Fig. 3b). As observed in Fig. 4(a) (physiologic buffer),
the uptake of carnosine was inhibited 30–40% by the
organic anions SITS and GABA, but not by TCA or PAH.
In contrast, there was no inhibition of carnosine by organic
acids when studied in low sodium buffer (Fig. 4b).
Carnosine was also inhibited 35–40% by the organic
cations NMN and TEA, but not by choline (Fig. 5a,
physiologic buffer). However, carnosine was not inhibited
by organic cations when studied under low sodium
conditions (Fig. 5b).
Apical uptake kinetics of carnosine in cell cultures
The inhibition studies suggested that carnosine may be
transported across the apical membrane by sodium-inde-
pendent (i.e. PEPT2) and sodium-dependent processes. In
order to assure the specificity of kinetic parameters, the
saturable uptake of carnosine was determined in low-Na+
aCSF buffer. This buffer has been shown to be advanta-
geous in studying the PEPT2-mediated transport of dipep-
tides in choroid plexus (Teuscher et al. 2000, 2001). As
shown in Fig. 6, the apical uptake of carnosine was of high
affinity in which Km and Vmax values were estimated at
34 ± 6 lM and 73 ± 5 pmol/mg protein/min, respectively.
Moreover, Kd values were small (i.e. 0.063 ± 0.007 lL/mg
protein/min) and, as a result, the carrier-mediated transport
accounted for > 97% of the total uptake under linear
conditions. A Woolf-Augustinsson-Hofstee plot of the
saturable data (Fig. 6, inset) was also linear (r2 ¼ 0.829),
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Fig. 1 Uptake amount of [3H]carnosine as a function of time from cell
monolayers (1 lM carnosine in external medium). (•) Uptake from the
apical chamber; (s) uptake from the basolateral chamber. Uptake is
linear through 120 min from both the apical and basolateral sides.
Studies were performed using normal-Na+ aCSF buffer, pH 7.4, in
both chambers. Data are expressed as mean ± SE (n ¼ 3–6).
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Fig. 2 Efflux of [3H]carnosine as a function of time from cell mono-
layers (after loading for 2 h with 1 lM [3H]carnosine). (•) Efflux into the
apical chamber; (s) efflux into the basolateral chamber. Data reported
as per cent of total carnosine effluxed at a given time point. Studies
were performed using normal-Na+ aCSF buffer, pH 7.4, in both
chambers. Data are expressed as mean ± SE (n ¼ 3–6).
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indicating that a single transport system was functioning
under low-Na+ conditions.
Endogenous carnosine
Given the substantial accumulation of carnosine in choroid
plexus, the in vivo concentrations of carnosine were
determined in several tissues and body fluids of rats. The
results in Table 1 demonstrate that there is a significant
amount of carnosine stored in the choroid plexus (100 lmol/
kg), as well as in the olfactory bulb (830 lmol/kg) and
skeletal muscle (1.78 mmol/kg). In contrast, carnosine levels
were below the limit of quantitation in CSF (< 2 lM) and
plasma (< 0.4 lM).
Carnosine uptake in isolated choroid plexuses
of PEPT2+/+ and PEPT2–/– mice
The uptake of carnosine was evaluated at 2 min, a value that
approximates initial rate uptake conditions in whole tissue
choroid plexus. In the presence of physiologic normal-Na+
aCSF buffer (Fig. 7), carnosine uptake was virtually elim-
inated in PEPT2–/– mice as compared with that in PEPT2+/+
mice (Vd ¼ 0.0436 lL/mg vs. 1.10 lL/mg, respectively;
p < 0.0001). A similar reduction was observed using low-
Na+ aCSF buffer (Vd ¼ 0.0481 lL/mg in PEPT2–/– mice vs.
0.675 lL/mg in PEPT2+/+ mice; p < 0.0001). Under both
conditions (i.e. normal and low sodium), the residual uptake
of carnosine was £ 7% in PEPT2 null animals.
Discussion
The choroid plexus performs a number of essential functions
in the brain. As the primary gatekeeper at the blood–
cerebrospinal fluid barrier (BCSFB), the choroid plexus has a
critical role in regulating the volume and composition of the





















































































6 Low Na+ aCSF
(a)
(b)
Fig. 4 Effect of organic anions on the apical uptake of [3H]carnosine
from cell monolayers (1 lM carnosine in external medium; inhibitor
concentrations at 1 mM). Studies were performed using normal-Na+
aCSF buffer, pH 7.4, in both chambers (a) or low-Na+ aCSF buffer,
pH 7.4, in both chambers (b). Data are expressed as mean ± SE














































































































Fig. 3 Effect of amino acids or dipeptides on the apical uptake of
[3H]carnosine from cell monolayers (1 lM carnosine in external med-
ium; inhibitor concentrations at 1 mM). Studies were performed using
normal-Na+ aCSF buffer, pH 7.4, in both chambers (a) or low-Na+
aCSF buffer, pH 7.4, in both chambers (b). Data are expressed as
mean ± SE (n ¼ 6–10 for controls; n ¼ 3–6 for inhibitors). **p < 0.01
as compared with control values.
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supportive glial cells. PEPT2 is expressed in choroid plexus,
however, its physiological function is still unclear. Peptide
transporters are known to serve a nutritive role in the
intestine and as a mechanism for peptide conservation in the
kidney (Leibach and Ganapathy 1996; Daniel and Herget
1997). Although PEPT2 may serve as a nutritive role by
supplying peptides to the choroid plexus and CSF from
blood, it more likely acts as a clearance mechanism to
remove unwanted peptides or peptide fragments from the
CSF. This belief is supported by studies on GlySar transport
and directionality, and the apical localization of PEPT2 in
choroid plexus (Teuscher et al. 2000; Shu et al. 2002).
Because these papers focused on a synthetic dipeptide, there
is little information on how endogenous peptides (and
neuropeptides) are handled at the blood–CSF interface.
Based on uptake studies in the absence and presence of
sodium, preliminary studies have suggested that PEPT2 has a
significant role in the choroid plexus uptake (about 30–60%)
of 5-aminolevulinic acid (Novotny et al. 2000), GlySar
(Teuscher et al. 2000) and carnosine (Teuscher et al. 2001).
However, a more recent study in PEPT2 knockout mice
(Shen et al. 2003) demonstrated that this transporter was
responsible for about 90% of the uptake of GlySar in isolated
choroid plexus under optimized conditions (i.e. Tris-MES
buffer, pH 6.5). The current studies use a combination of rat
choroid plexus primary cell cultures and transgenic mice to
further probe the role of PEPT2 in neuropeptide homeostasis
in the CSF under physiologic conditions.
We found that carnosine exhibited a preferential uptake at
the apical membrane of the choroid plexus epithelial cells.
However, there was no measurable transcellular transport of
carnosine from the apical to basolateral chambers. This
finding is supported by the low basolateral efflux, which
measured only 5% at 25 min. Instead, it appears that once
carnosine enters the choroid plexus from the CSF-facing
side, it accumulates substantially within the cells, achieving
concentrations 135 · higher than that of extracellular
medium and in vivo levels of 100 lmol/kg. The culturing
medium did not contain carnosine, which might suggest that
our uptake studies demonstrate a replenishment of carnosine
stores in various intracellular compartments. Our efflux
results also indicate that some carnosine can recycle back to
the CSF. The lack of carnosine transepithelial transport
differs from studies by Shu et al. (2002) who demonstrated
that GlySar was effluxed at the basolateral membrane. It is
possible that carnosine and GlySar share a common uptake
Fig. 6 Concentration-dependent apical uptake of [3H]carnosine from
cell monolayers (1–500 lM total carnosine in external medium).
Studies were performed using low-Na+ aCSF buffer, pH 7.4, in both
chambers. The experimental data (•) are expressed as mean ± SE
(n ¼ 3–6). The predicted curves were generated using the Vmax, Km
and Kd values, as determined by non-linear regression (r
2 > 0.990)
and reported in the text. The insert is a Woolf-Augustinsson-Hofstee






























































































Fig. 5 Effect of organic cations on the apical uptake of [3H]carnosine
from cell monolayers (1 lM carnosine in external medium; inhibitor
concentrations at 1 mM). Studies were performed using normal-Na+
aCSF buffer, pH 7.4, in both chambers (a) or low-Na+ aCSF buffer,
pH 7.4, in both chambers (b). Data are expressed as mean ± SE
(n ¼ 6–10 for controls; n ¼ 3–6 for inhibitors). **p < 0.01 as compared
with control values.
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pathway (i.e. PEPT2), but have different cellular efflux
mechanisms at the basolateral membrane.
The apical uptake of carnosine was one of high affinity
(Km ¼ 34 lM) and low capacity (Vmax ¼ 73 pmol/mg pro-
tein/min), and was consistent with a PEPT2-mediated
process. In addition, the Km determined for carnosine in this
study (rat choroid plexus primary cell cultures) compared
favorably with the Km of 39.3 lM reported previously for
carnosine in isolated choroid plexus experiments (Teuscher
et al. 2001). The preferential and high-affinity uptake of
carnosine further support the belief that PEPT2 serves as an
efflux pump to clear peptides from the CSF. PEPT2 is well
suited for this task as its Km values are generally in the lM
range for most di- and tripeptides. Working in concert with
apically expressed peptidases in the choroid plexus (Smith
et al. 2004), PEPT2 can effectively clear low concentrations
of neuropeptides and/or their metabolites. A lack of inhibi-
tion by the constituent amino acids of carnosine (i.e.
b-alanine and L-histidine), coupled with the stability of intact
radiolabel, indicate that carnosine metabolism is not a
confounding factor in these experiments. In addition, the
peptide/histidine transporters, PHT1 and PHT2, do not
appear to mediate carnosine uptake as demonstrated by the
lack of inhibition by L-histidine at concentrations 50 times its
Km value (Yamashita et al. 1997) and because of results in
the PEPT2 transgenic mice.
The studies in transgenic mice clearly demonstrate that
PEPT2 accounts for over 90% of carnosine’s uptake in
choroid plexus whole tissue. The lack of difference in null
animals as a function of sodium (normal-Na+ vs. low-Na+
aCSF buffer) suggests that residual sodium-dependent
transport mechanisms are not present. Yet, under low
sodium conditions, the uptake of carnosine was reduced
by 39% in wild-type mice. In previous studies (Novotny
et al. 2000; Teuscher et al. 2001), this finding would have
been mistakenly interpreted as PEPT2 being responsible for
61% of carnosine’s uptake with another 39% being handled
by Na+-dependent processes. As a result, one must use
caution when interpreting data from different buffer condi-
tions. Although PEPT2-mediated transport is proton-cou-
pled, as opposed to being Na+-coupled, it is a tertiary active
process that depends on prior sodium and hydrogen ion
gradients being established. To further probe this relation-
ship, we studied the effect of a Na+/H+ exchange inhibitor,
dimethyl amiloride (1 mM), on the apical uptake of
[3H]carnosine (1 lM) in rat choroid plexus primary cell
cultures. Using normal-Na+ aCSF buffer conditions,
carnosine uptake was inhibited by 88% (p < 0.01 as
compared with control values), demonstrating the profound
influence of Na+/H+ exchange on the PEPT2-mediated
transport of a dipeptide.
Although speculative, the minor inhibition observed by
some organic anions (i.e. SITS and GABA, but not TCA and
PAH) and cations (i.e. NMN and TEA, but not choline)
probably reflects alterations in membrane potential and/or
microclimate pH, thereby resulting in reduced uptake of
carnosine in choroid plexus. It is highly unlikely that other
transporters are involved because, as shown in this study,
PEPT2 appears to account for essentially all of carnosine’s
transport into choroid plexus. As shown with GlySar (Shen
et al. 2003) and cefadroxil (Ocheltree et al. 2004) in








Skeletal muscle 1.78 ± 0.03 0.7–1.36 (Chung-Hwang et al. 1976; O’Dowd et al. 1990; Ward and Preedy 1992)
Olfactory bulb 0.83 ± 0.01 0.9–2.7 (Margolis 1974; Ferriero and Margolis 1975)
Choroid plexus 0.10 ± 0.02 – –
CSF < LOQ 0 (Kish et al. 1979)
Plasma < LOQ – –
aData are reported as mean ± SE (n ¼ 3). bData are reported as range. cLOQ represents the limit of quantitation (0.002 mM for CSF and
























+/+          -/-         +/+          -/- 
aCSF Buffer       Low Na+ aCSF
*** ***
Fig. 7 Uptake of [3H]carnosine in the isolated choroid plexuses of
PEPT2+/+ and PEPT2–/– mice (1 lM carnosine in external medium).
Studies were performed using normal-Na+ aCSF buffer, pH 7.4, or
low-Na+ aCSF buffer, pH 7.4, in both genotypes. Data are expressed
as mean ± SE (n ¼ 3–4). ***p < 0.001 as compared with wild-type
animals.
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transgenic mice, only 5% of choroid plexus uptake occurs, in
general, by non-specific processes.
In conclusion, these studies are unique in first demonstra-
ting the preferential apical uptake of an endogenous neuro-
peptide at the BCSFB, and the importance of PEPT2 in this
process. These findings establish that PEPT2 is responsible
for over 90% of carnosine’s choroid plexus uptake, and
suggest a critical role for PEPT2 in neuropeptide homeostasis
in the central nervous system. Although PEPT2 transports a
wide range of di- and tripeptides, peptide disposition may
vary once in the cell. Thus, some peptides may be
accumulated in the choroid plexus, as observed in this study
for carnosine. Others may be effluxed into blood, as found
for GlySar (Shu et al. 2002). Yet others may be metabolized
intracellularly by the choroid plexus and then recycled. In
order to more completely understand the role of PEPT2 in the
brain, our laboratory is currently investigating the in vivo
pharmacokinetics and tissue distribution of peptides/mime-
tics in wild-type and PEPT2 knockout mice.
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